Drug Shortage Report for COLESTID GRANULES
Report ID | 135849 |
Drug Identification Number | 00642975 |
Brand name | COLESTID GRANULES |
Common or Proper name | Colestid 5g |
Company Name | PFIZER CANADA ULC |
Market Status | DORMANT |
Active Ingredient(s) | COLESTIPOL HYDROCHLORIDE |
Strength(s) | 5G |
Dosage form(s) | GRANULES |
Route of administration | ORAL ORAL |
Packaging size | Pouch 30's |
ATC code | C10AC |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-03-17 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-04-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2025-04-15 | English | Compare |
v4 | 2024-01-30 | English | Compare |
v3 | 2021-03-18 | English | Compare |
v2 | 2021-03-17 | French | Compare |
v1 | 2021-03-17 | English | Compare |
Showing 1 to 5 of 5